Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance

Despite significant improvements in prognosis, a subset of patients with primary central nervous system lymphoma (PCNSL) remains at high risk for relapse. The treatment of relapsed and refractory (R/R) PCNSL remains a major clinical challenge. Herein, we present a 24-year-old patient with PCNSL who...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Luyao Wang, Yili Fan, Boxiao Chen, Jiawei Zhang, Luyu Yang, Xi Qiu, Huawei Jiang, Jinfan Li, Xibin Xiao, Liansheng Huang, Yang Xu
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2024-01-01
سلاسل:	Frontiers in Oncology
الموضوعات:	primary central nervous system lymphoma thiotepa autologous stem cell transplantation anti-PD-1 antibody maintenance therapy
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1333761/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!